* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Cardio113-ValsalvaManeuver
Coronary artery disease wikipedia , lookup
Artificial heart valve wikipedia , lookup
Heart failure wikipedia , lookup
Jatene procedure wikipedia , lookup
Myocardial infarction wikipedia , lookup
Electrocardiography wikipedia , lookup
Mitral insufficiency wikipedia , lookup
Cardiac surgery wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
Cardio #113 Mon 02/10/03 Dr. Smith Troy Phillips Valsalva Maneuver I. Valsalva Maneuver a. Performed by closing the glottis (or using a closed mouthpiece) and then trying to force air out (for at least 10 seconds) causing intrathoracic pressure to rise. b. Used clinically to assess central hemodynamic function, arterial baroreflex function and valve function. c. Phases are dictated by changes in blood pressure which “better be the same” as left ventricular pressure. II. 4 phases (in healthy patient) a. Phase 1 1. Brief increase in arterial pressure due to compression of ventricles, aorta and large arteries. 2. Causes brief increase in stroke volume, BP and cardiac work with no change in HR. b. Phase 2 1. Marked by sharp decrease in blood pressure (may plateau) 2. Elevated intrathoracic pressure tends to collapse vena cava where they enter thoracic cavity causing significant decrease in venous return which then leads to a decrease in preload, SV, CO, and arterial pressure. All of this in turn leads to a baroreflex mediated increase in HR c. Phase 3 1. Marked by stopping maneuver which relieves intrathoracic pressure. 2. Reverse of events of stage 1. 3. Left side has drop in output while right side has an increase in output due to increase venous return. 4. Venous return and cardiac output are mismatched for a couple of heartbeats. d. Phase 4 1. Increase in venous return which leads to increase in preload, SV, CO, and BP. All of this in turn leads to baroreflex mediated decrease in HR. 2. Occurs within 1-6 heart beats. Exam Question: Is a β1 adrenergic blocker going to affect heart rate during phase 2? No, there is no sympathetic control in phase 2, only parasympathetic. 1 Cardio #113 Mon 02/10/03 Dr. Smith Troy Phillips During Each Phase Venous return Preload Stroke volume Cardiac output Velocity of shortening Heart rate Sympathetic NA Parasympathetic NA Blood Pressure III. IV. 1 ↓↓ ↓ ↑ (init.) ↓ ↑ (init.) ↓ ↓ ↓ (slight) ↓ ↑ ↑ 2 ↓ ↓ ↓ ↓ ↑ ↑ ↓ ↓ 3 ↑ ↑ ↓ ↓ ↑ ↑ ↑ ↓ ↓ 4 ↑ ↑ ↑ ↑ ↓ ↓ ↓ ↑ ↑ Uses of the Valsalva Maneuver a. Assess hemodynamic function 1. Main focus is on BP response 2. Effect of graded Valsalva straining 3. Supine vs. upright i. supine resembles heart failure due to increased volume around heart ii. astronauts (weightlessness) resemble supine position due to “headward shift” of blood volume b. Assess baroreflex function 1. Focus is phase II and IV 2. Relative HR response to BP response i. as blood pressure increases, heart rate should decrease (baroreceptor control, lacking in heart failure) 3. DBP response to phase IV gives an indication of the vasopressor response. c. Assess valve function 1. Many murmurs are reduced due to decreased stroke volume and cardiac output. i. Take home question: Which phases would you expect to see decreased murmurs? 2. Phase IV can help distinguish right heart murmurs from left heart murmurs i. very transient Valsalva Maneuver in CHF a. Resembles Valsalva maneuver performed while supine 1. due to increased fluid volume around heart b. Phases II and IV are unclear 1. “Square wave” response 2 Cardio #113 Mon 02/10/03 Dr. Smith Troy Phillips c. Diuretics should improve Valsalva maneuver results in CHF 1. Diuretics act to reduce fluid around heart *Review diagrams in power points of normal Valsalva vs. CHF 3